Transcranial Doppler Ultrasound Velocity Measurements in Children With Sickle Cell Disease in Kenya

Catherine Mwalimu1,2, Oscar Odhiambo3,4, Elaine Mashisia3

  • 1Department of Paediatrics and Child Health Aga Khan University Hospital Nairobi Kenya.

Ejhaem
|May 21, 2026
PubMed

Insights

Sickle cell disease (SCD) screening using transcranial Doppler (TCD) showed low abnormal velocities in children on hydroxyurea. Normal TCD values in healthy children provide local reference data for stroke risk assessment.

Area of Science:

  • Neurology
  • Pediatrics
  • Hematology

Background:

  • Sickle cell disease (SCD) is a prevalent inherited blood disorder in Sub-Saharan Africa.
  • Children with SCD face a high risk of ischemic stroke.
  • Transcranial Doppler (TCD) ultrasonography is crucial for identifying children at elevated stroke risk.

Purpose of the Study:

  • To determine the prevalence of abnormal cerebral blood flow velocity (CBFV) in children with SCD.
  • To describe CBFV in children without SCD for comparison.

Main Methods:

  • A two-component study involving retrospective TCD data review and a cross-sectional assessment.
  • TCD measurements were analyzed in 143 children with SCD (aged 2-16) and 17 children without SCD (aged 3-11).
  • Standardized middle cerebral artery (MCA) TCD assessments were performed and velocities categorized.

Main Results:

  • Among 143 children with SCD on hydroxyurea, 1.4% had high TCD velocities (≥200 cm/s) and 4.9% had low velocities (<50 cm/s).
  • TCD velocities showed no association with demographic, clinical characteristics, or hemoglobin levels.
  • In children without SCD, MCA velocities were normal (50-149 cm/s), age-dependent, and symmetrical.

Conclusions:

  • Abnormal TCD velocities were infrequent in children with SCD receiving hydroxyurea.
  • Normal MCA velocities in children without SCD establish local reference values.
  • CBFV variability underscores the need for continued annual TCD screening for accurate stroke-risk classification.
Abstract